European Journal of Cancer
Volume 48, Issue 3 , Pages 377-384 , February 2012

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

  • Gianfranco A. Pesce

      Affiliations

    • Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
    • Corresponding Author InformationCorresponding author: Address: Oncology Institute of Southern Switzerland, 6500 Bellinzona, Switzerland. Tel.: +41 91 811 9443; fax: +41 91 811 8678.
    • ,
  • Dirk Klingbiel

      Affiliations

    • Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland
    • ,
  • Karin Ribi

      Affiliations

    • International Breast Cancer Study Group (IBCSG) Coordinating Center, Bern, Switzerland
    • ,
  • Abderahim Zouhair

      Affiliations

    • University of Lausanne Hospital (CHUV), Lausanne, Switzerland
    • ,
  • Roger von Moos

      Affiliations

    • Kantonsspital Graubünden, Chur, Switzerland
    • ,
  • Marc Schlaeppi

      Affiliations

    • Kantonsspital St. Gallen, St. Gallen, Switzerland
    • ,
  • Clemens B. Caspar

      Affiliations

    • Kantonsspital Baden, Baden, Switzerland
    • ,
  • Natalie Fischer

      Affiliations

    • University Hospital, Basel, Switzerland
    • ,
  • Sandro Anchisi

      Affiliations

    • Spital Wallis, Sion, Switzerland
    • ,
  • Solange Peters

      Affiliations

    • University of Lausanne Hospital (CHUV), Lausanne, Switzerland
    • ,
  • Richard Cathomas

      Affiliations

    • Kantonsspital Graubünden, Chur, Switzerland
    • ,
  • Jürg Bernhard

      Affiliations

    • International Breast Cancer Study Group (IBCSG) Coordinating Center, Bern, Switzerland
    • ,
  • Nina M. Kotrubczik

      Affiliations

    • Kantonsspital Aarau, Aarau, Switzerland
    • ,
  • Giannicola D’Addario

      Affiliations

    • Kantonsspital St. Gallen, St. Gallen, Switzerland
    • ,
  • Christiane Pilop

      Affiliations

    • Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland
    • ,
  • Damien C. Weber

      Affiliations

    • Geneva University Hospital, Geneva, Switzerland
    • ,
  • Stephan Bodis

      Affiliations

    • Kantonsspital Aarau, Aarau, Switzerland
    • ,
  • Miklos Pless

      Affiliations

    • Kantonsspital Winterthur, Winterthur, Switzerland
    • ,
  • Michael Mayer

      Affiliations

    • Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland
    • ,
  • Roger Stupp

      Affiliations

    • University of Lausanne Hospital (CHUV), Lausanne, Switzerland

Received 11 October 2011 ,Accepted 13 October 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(11)00823-9

doi: 10.1016/j.ejca.2011.10.016

European Journal of Cancer
Volume 48, Issue 3 , Pages 377-384 , February 2012

Article Tools

* Image Usage & Resolution